BioCentury | Sep 15, 2016
Distillery Therapeutics

Therapeutics: Sudan ebolavirus RNA-dependent RNA polymerase cofactor VP35 (SUDV VP35)

...Infectious disease INDICATION: Ebola Non-human primate studies suggest siRNA targeting SUDV VP35 could help treat Sudan ebolavirus...
...infection. In rhesus macaques challenged with lethal doses of Sudan ebolavirus, lipid nanoparticle-encapsulated siRNA targeting SUDV VP35...
...Next steps could include testing the siRNA in other animal models of Ebola infection. TARGET/MARKER/PATHWAY: Sudan ebolavirus RNA-dependent RNA polymerase cofactor VP35 (SUDV VP35)...
Items per page:
1 - 1 of 1